Immix Biopharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $15 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Immix Biopharma is raising $15,000,000.00 in new funding. About Immix Biopharma: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology…